BREAKING NEWS
Sarepta shares slide again as drugmaker bows to FDA pressure to pause gene therapy
Read full article: Sarepta shares slide again as drugmaker bows to FDA pressure to pause gene therapySarepta Therapeutics is pausing shipments of its gene therapy for muscular dystrophy following several patient deaths that have attracted attention from regulators.